These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 22119914

  • 1. The influence of obesity on progression of coronary arteriosclerosis and clinical course after ST elevation acute myocardial infarction treated with primary coronary interventions.
    Pietrucha AZ, Stryjewski PJ, El-Massri N, Gajos G, Kruszelnicka O, Badacz L, Piwowarska W, Nessler J.
    Adv Med Sci; 2011; 56(2):241-8. PubMed ID: 22119914
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of plasma renin activity in acute myocardial infarction patients treated with primary percutaneous coronary interventions].
    Stryjewski PJ, Pietrucha AZ, Stopyra K, Nessler B, Kruszelnicka O, Gackowski A, Konduracka E, Sztefko K, Badacz L, Nessler J.
    Przegl Lek; 2011; 68(7):354-8. PubMed ID: 22010471
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
    Tarantini G, Napodano M, Gasparetto N, Favaretto E, Marra MP, Cacciavillani L, Bilato C, Osto E, Cademartiri F, Musumeci G, Corbetti F, Razzolini R, Iliceto S.
    Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
    [Abstract] [Full Text] [Related]

  • 5. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ.
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.
    Elbarouni B, Cantor WJ, Ducas J, Borgundvaag B, Džavík V, Heffernan M, Buller CE, Langer A, Goodman SG, Yan AT, TRANSFER-AMI Trial Investigators.
    Can J Cardiol; 2014 Dec; 30(12):1555-61. PubMed ID: 25475460
    [Abstract] [Full Text] [Related]

  • 10. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB.
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.
    J Invasive Cardiol; 2013 Mar; 25(3):114-7. PubMed ID: 23468438
    [Abstract] [Full Text] [Related]

  • 14. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Kang WY, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, Rha SW, Bae JH, Cho JG, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    J Cardiol; 2010 Jan; 55(1):84-91. PubMed ID: 20122553
    [Abstract] [Full Text] [Related]

  • 15. Risk factors of asymptomatic restenosis in patients with first anterior ST elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Wita K, Kinasz L, Filipecki A, Lelek M, Szczogiel J, Turski M, Weglarz P, Elzbieciak M, Staroń A, Trusz-Gluza M.
    Kardiol Pol; 2010 Sep; 68(9):987-93. PubMed ID: 20859886
    [Abstract] [Full Text] [Related]

  • 16. No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.
    Akin I, Tölg R, Hochadel M, Bergmann MW, Khattab AA, Schneider S, Senges J, Kuck KH, Richardt G, Nienaber CA, DES.DE (German Drug-Eluting Stent) Study Group.
    JACC Cardiovasc Interv; 2012 Feb; 5(2):162-9. PubMed ID: 22361600
    [Abstract] [Full Text] [Related]

  • 17. Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.
    Kübler P, Jankowska EA, Ferenc M, Ponikowski P, Banasiak W, Reczuch K.
    Kardiol Pol; 2013 Feb; 71(1):25-31. PubMed ID: 23348530
    [Abstract] [Full Text] [Related]

  • 18. Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions.
    Mehta RH, O'neill WW, Harjai KJ, Cox DA, Brodie BR, Boura J, Grines L, Stone GW, Grines CL, Primary Angioplasty in Myocardial Infarction (PAMI) and the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators.
    Am J Cardiol; 2006 Mar 15; 97(6):817-22. PubMed ID: 16516582
    [Abstract] [Full Text] [Related]

  • 19. Management of multivessel coronary disease after ST elevation myocardial infarction treated by primary angioplasty.
    Rigattieri S, Biondi-Zoccai G, Silvestri P, Di Russo C, Musto C, Ferraiuolo G, Loschiavo P.
    J Interv Cardiol; 2008 Feb 15; 21(1):1-7. PubMed ID: 18086133
    [Abstract] [Full Text] [Related]

  • 20. Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents.
    Sarno G, Räber L, Onuma Y, Garg S, Brugaletta S, van Domburg RT, Pilgrim T, Pfäffli N, Wenaweser P, Windecker S, Serruys P.
    Am J Cardiol; 2011 Jul 15; 108(2):195-201. PubMed ID: 21529741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.